Ireland
--:--IST
Latest
Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide The €100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany Ireland's €93.8 Billion Non-EU Pharma Export Engine: 2025 Eurostat Trade Data and Economic Impact Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide The €100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany Ireland's €93.8 Billion Non-EU Pharma Export Engine: 2025 Eurostat Trade Data and Economic Impact
Priya Life Science Clinical trial register
Trackers› Clinical trials› Hefei
Clinical trial register · China

Clinical Trials in Hefei, 2026

Every study on the ClinicalTrials.gov registry that lists a site in China and is open, about to open, active-but-closed, or enrolling by invitation. Filter it, cite it, and take it away as a file.

Download CSV
Source: ClinicalTrials.gov, U.S. National Library of Medicine. Complete coverage — all 19224 matching records held by the registry are in this view. Synced 11 Nov 2026, 03:17 UTC
19224
Studies in scope
all four open statuses
11811
Recruiting now
open to new participants
2030
Lead sponsors
across recruiting studies
Top sites
Guangzhou 4 Beijing 3 Hefei 2 Nanchang 2 Wuhu 2
Narrow the registerReset
Recruitment status
Phase
Lead sponsor
Anhui Provincial Hospital59 Merck Sharp & Dohme LLC36 Anhui Medical University29 AstraZeneca26 Eli Lilly and Company25 Chia Tai Tianqing Pharmaceutical Group Co., Ltd.22 Pfizer19 Tianjin Medical University17 The Second Hospital of Anhui Medical University17 Anhui Provincial Cancer Hospital15 Bristol-Myers Squibb15 The First Affiliated Hospital of Anhui Medical University13 Novartis Pharmaceuticals12 Beijing InnoCare Pharma Tech Co., Ltd.11 Chia Tai Tianqing Pharmaceutical Group Nanjing Shunxin Pharmaceutical Co., Ltd.11 Hoffmann-La Roche10 BeOne Medicines10 Shanghai Henlius Biotech9 The First Affiliated Hospital of University of Science and Technology of China8 Institute of Hematology & Blood Diseases Hospital, China7 BeiGene7 Sanofi6 AbbVie6 BioNTech SE6 Takeda6 Vigonvita Life Sciences6 Boehringer Ingelheim6 First Affiliated Hospital of Zhejiang University6 DualityBio Inc.6 Shanghai Chia Tai Tianqing Pharmaceutical Technology Development Co., Ltd.6 MediLink Therapeutics (Suzhou) Co., Ltd.5 Amgen5 Abbisko Therapeutics Co, Ltd5 Innovent Biologics (Suzhou) Co. Ltd.5 Loxo Oncology, Inc.5 PersonGen BioTherapeutics (Suzhou) Co., Ltd.5 Daiichi Sankyo5 Antengene Biologics Limited4 Shanghai Junshi Bioscience Co., Ltd.4 Janssen Research & Development, LLC4 First Affiliated Hospital of Ningbo University4 Akeso4 Shanghai Pulmonary Hospital, Shanghai, China4 Cascade Pharmaceuticals, Inc4 Fudan University4 Tongji Hospital4 Shanghai Zhongshan Hospital4 Dizal Pharmaceuticals4 Hutchmed4 Hansoh BioMedical R&D Company4 Sichuan Baili Pharmaceutical Co., Ltd.4 Nanjing Leads Biolabs Co.,Ltd4 Beijing HuiLongGuan Hospital3 Children's Hospital of Fudan University3 Innostellar Biotherapeutics Co.,Ltd3 Xiamen Amoytop Biotech Co., Ltd.3 Shenzhen Salubris Pharmaceuticals Co., Ltd.3 Shanghai Pharmaceuticals Holding Co., Ltd3 Shenzhen MagicRNA Biotechnology Co., Ltd3 Gilead Sciences3 Peking University First Hospital3 Hangzhou Gensciences Biopharmaceutical Co., Ltd.3 Bai-Rong Xia3 Hangzhou Zhongmei Huadong Pharmaceutical Co., Ltd.3 Mirati Therapeutics Inc.3 Jiangsu HengRui Medicine Co., Ltd.3 Nanfang Hospital, Southern Medical University3 Allist Pharmaceuticals, Inc.3 Second Affiliated Hospital, Zhejiang University, School of Medicine3 Beijing Anzhen Hospital3 Karuna Therapeutics, Inc., a Bristol Myers Squibb company2 Jiangsu Simcere Pharmaceutical Co., Ltd.2 Simcere Pharmaceutical Co., Ltd2 Astellas Pharma Global Development, Inc.2 Lee's Pharmaceutical Limited2 Union Hospital, Tongji Medical College, Huazhong University of Science and Technology2 Tasly Pharmaceutical Group Co., Ltd2 West China Hospital2 Jiangsu Hansoh Pharmaceutical Co., Ltd.2 Fujian Shengdi Pharmaceutical Co., Ltd.2 CorrectSequence Therapeutics Co., Ltd2 Peking Union Medical College Hospital2 Sinovac Biotech Co., Ltd2 InventisBio Co., Ltd2 Haihe Biopharma Co., Ltd.2 Huashan Hospital2 Bambusa Therapeutics2 Sunshine Lake Pharma Co., Ltd.2 Chongqing Precision Biotech Co., Ltd2 GlaxoSmithKline2 Shanghai Huilun Pharmaceutical Co., Ltd.2 Guangzhou Lupeng Pharmaceutical Company LTD.2 TCRx Therapeutics Co.Ltd2 Zai Lab (Shanghai) Co., Ltd.2 Seagen, a wholly owned subsidiary of Pfizer2 Medtronic2 Laekna Limited2 First Affiliated Hospital of Wannan Medical College2 Biotheus Inc.2 Peking University Third Hospital2 Nanjing RegeneCore Biotech Co., Ltd.2 Celgene2 Bayer2 Shanghai RAAS Blood Products Co., Ltd.2 Qilu Pharmaceutical Co., Ltd.2 West China Second University Hospital2 Ausper Biopharma Co., Ltd.2 Southeast University, China2 EMD Serono Research & Development Institute, Inc.2 ArriVent BioPharma, Inc.2 The First Affiliated Hospital of Soochow University2 China National Center for Cardiovascular Diseases2 Children's Hospital of Soochow University2 Yanghua Tian2 Chengdu Zenitar Biomedical Technology Co., Ltd2 Capital Medical University2 Zhimin Zhai2 Biogen2 Shuanghu Yuan2 The First Affiliated Hospital with Nanjing Medical University2 Chongqing Claruvis Pharmaceutical Co., Ltd.2 Novo Nordisk A/S2 The United Bio-Technology (Hengqin) Co., Ltd.2 TransThera Sciences (Nanjing), Inc.2 Sun Yat-sen University2 Bin Cao2 First Hospital of China Medical University2 Shanghai Jiao Tong University School of Medicine2 RemeGen Co., Ltd.2 The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School2 Cancer Institute and Hospital, Chinese Academy of Medical Sciences2 Shanghai Chest Hospital2 Ascentage Pharma Group Inc.2 Gritgen Therapeutics Co., Ltd.2 Daehwa Pharmaceutical Co., Ltd.1 Zhiquan Hu1 Fortvita Biologics (USA)Inc.1 Guang'anmen Hospital of China Academy of Chinese Medical Sciences1 Xcovery Holdings, Inc.1 Green Valley (Shanghai) Pharmaceuticals Co., Ltd.1 MindRank AI Ltd1 Juventas Cell Therapy Ltd.1 Peking University People's Hospital1 Children's Hospital of Chongqing Medical University1 Shandong Provincial Hospital1 argenx1 Chunyan Zhu1 Third Affiliated Hospital, Sun Yat-Sen University1 Jinling Hospital, China1 JHM BioPharma (Tonghua) Co. , Ltd.1 Shanghai Argo Biopharmaceutical Co., Ltd.1 Chinese University of Hong Kong1 Exelixis1 Jian Cheng1 Shanghai Xinzhi BioMed Co., Ltd.1 ScinnoHub Pharmaceutical Co., Ltd.1 Innovent Biopharmaceutical Technology (Hangzhou) Co., LTD.1 Central South University1 Junjie Xu1 Foresight Therapeutics (Hefei) Co., Ltd.1 Wayshine Biopharm, Inc.1 The Affiliated Hospital Of Guizhou Medical University1 The First Affiliated Hospital of Dalian Medical University1 China Immunotech (Beijing) Biotechnology Co., Ltd.1 Nuvation Bio Inc.1 DK Medical Technology (Suzhou) Co., Ltd.1 Fujian Medical University1 Second Affiliated Hospital of Nanchang University1 Beijing Pins Medical Co., Ltd1 DSciLab Co., Ltd.1 Kunming Pharmaceuticals, Inc.1 Shandong Suncadia Medicine Co., Ltd.1 Jacobio Pharmaceuticals Co., Ltd.1 Zhongshan Sansure Hygene Biomedicine Co., Ltd.1 Jia Fan1 The Hong Kong Polytechnic University1 Shuangyue Liu1 Broadenbio Ltd., Co.1 Hefei Cancer Hospital of the Chinese Academy of Sciences1 Hinova Pharmaceuticals Inc.1 Genfleet Therapeutics (Shanghai) Inc.1 Beijing Hospital1 Inventiva Pharma1 Nanjing Legend Biotech Co.1 Tianjin Medical University General Hospital1 Shanghai United Cell Biotechnology Co., Ltd1 Chengdu SciMount Pharmatech Co., Ltd.1 Jiangsu Healthy Life Innovation Medical Technology Co., Ltd1 Dermavon Holdings Limited1 The Children's Hospital of Zhejiang University School of Medicine1 Chinese PLA General Hospital1 Tyligand Pharmaceuticals (Suzhou) Limited1 Suzhou Puhe Pharmaceutical Technology Co., LTD1 Sellas Life Sciences Group1 Advenchen Laboratories, LLC1 Ningbo Newbay Technology Development Co., Ltd1 Chinese SLE Treatment And Research Group1 Zenith Epigenetics1 Wen-hong Zhang1 Hangzhou GluBio Pharmaceutical Co., Ltd.1 Zhejiang Wolwo Bio-Pharmaceutical Co., Ltd.1 Lepu Medical Technology (Beijing) Co., Ltd.1 Helixon Biotechnology (Suzhou) Co., Ltd1 Taizhou Hanzhong biomedical co. LTD1 Skyline Therapeutics1 Ocumension Therapeutics (Suzhou) Co., Ltd1 Alpha Biopharma (Jiangsu) Co., Ltd.1 Haisco Pharmaceutical Group Co., Ltd.1 Santen Pharmaceutical Co., Ltd.1 Fangbiao Tao1 Anhui Provincial Children's Hospital1 The First Affiliated Hospital of Hainan Medical University1 GeneQuantum Healthcare (Suzhou) Co., Ltd.1 Jiangsu BioJeTay Biotechnology Co., Ltd.1 Guangdong Second Provincial General Hospital1 Xiang Yang Zhang1 Acepodia Biotech, Inc.1 Beijing GoBroad Hospital1 Shanghai Mental Health Center1 Shanghai SciBrunch Therapeutics Co., Ltd.1 InSilico Medicine Hong Kong Limited1 Evopoint Biosciences Inc.1 Shanghai Tong Ren Hospital1 WANG KAI1 Ganzhou Hemay Pharmaceutical Co., Ltd1 The Second Affiliated Hospital of Anhui University of Traditional Chinese Medicine1 CSPC Zhongnuo Pharmaceutical (Shijiazhuang) Co., Ltd.1 Genor Biopharma Co., Ltd.1 Permed Biomedical Engineering Co., Ltd1 Dianthus Therapeutics1 Changchun GeneScience Pharmaceutical Co., Ltd.1 OncoC4, Inc.1 Skyline Therapeutics (US) Inc.1 Suzhou Biomissile Pharmaceuticals Co., Ltd.1 RenJi Hospital1 Huahui Health1 CStone Pharmaceuticals1 Base Therapeutics (Shanghai) Co., Ltd.1 Jiangsu Jingze Biopharmaceutical Co., Ltd.1 iRegene Therapeutics Co., Ltd.1 Candid Therapeutics1 Celest Therapeutics (Shanghai) Co., Ltd.1 Beijing Inno Medicine Co., Ltd.1 Suzhou Suncadia Biopharmaceuticals Co., Ltd.1 Wei Hu1 Zhigang Li1 Beijing Continent Pharmaceutical Co, Ltd.1 Shanghai Gynecologic Oncology Group1 Shanghai Allink Biotherapeutics Co., Ltd.1 CARsgen Therapeutics Co., Ltd.1 Celregen Therapeutics1 Nuwacell Biotechnologies Co., Ltd.1 Hangzhou DAC Biotechnology Co., Ltd.1 Chengdu Qingshan Likang Pharmaceutical Co., Ltd1 Jazz Pharmaceuticals1 Jiangsu Alphamab Biopharmaceuticals Co., Ltd1 Climb Bio, Inc.1 Jiangsu Carephar Pharmaceutical Co., Ltd.1 Mabwell (Shanghai) Bioscience Co., Ltd.1 Resonova (Shanghai) Medtech Limited1 Chinese Academy of Medical Sciences, Fuwai Hospital1 Lyvgen Biopharma Holdings Limited1 Nanjing First Hospital, Nanjing Medical University1 Guangzhou Virotech Pharmaceutical Co., Ltd.1 Sinovac Life Sciences Co., Ltd.1 Suzhou Mednovo Yi Medical Technology Co., Ltd.1 Xuanwu Hospital, Beijing1 Nanjing IASO Biotechnology Co., Ltd.1 TJ Biopharma Co., Ltd.1 Tianjin Medical University Cancer Institute and Hospital1 Anhui Chest Hospital1 I-Mab Biopharma US Limited1 Ferring Pharmaceuticals1 Keymed Biosciences Co.Ltd1 Zenas BioPharma (USA), LLC1 Klus Pharma Inc.1 Tong Chen, MD1 Shanghai University of Traditional Chinese Medicine1 ImmuneOnco Biopharmaceuticals (Shanghai) Inc.1 Forward Pharmaceuticals Co., Ltd.1 Oupushifang Pharmaceutical Technology Co., Ltd.1 ZHOU FANGJIAN1 Shenzhen Fosun Kairos Biotechnology Co., Ltd.1 Xian-Janssen Pharmaceutical Ltd.1 Shenzhen Core Medical Technology CO.,LTD.1 Ruijin Hospital1 BioDlink Biopharm Co., Ltd.1 Vor Biopharma1 Hospital Affiliated to the Institute of Neurology, Anhui University of Chinese Medicine1 3D Medicines (Sichuan) Co., Ltd.1 Suzhou Genhouse Bio Co., Ltd.1 Suzhou Hengruihongyuan Medical Technology Co. LTD1 AriBio Co., Ltd.1 Medtecx Co Ltd.1 JIANGSU SHENMING Medical Technology CO., Ltd1 Waterstone Pharmaceutical (Wuhan) Co., LTD.1 Nanjing Sanhome Pharmaceutical, Co., Ltd.1 PharmaEssentia1 AlphaNa Bioscience Company Limited1 Wan-Jin Chen1 YiLin Zhao1 Beijing Sungen Biomedical Technology Co., Ltd1 D3 Bio (Wuxi) Co., Ltd1 CSPC ZhongQi Pharmaceutical Technology Co., Ltd.1 Chongqing Peg-Bio Biopharm Co., Ltd.1 Ming-Yuan Chen1 Guangdong Association of Clinical Trials1 Junbo Ge1 Bivision Pharmaceuticals, Inc.1 Nanjing Minova Pharmaceutical Co., Ltd.1 Betta Pharmaceuticals Co., Ltd.1 Beijing Suncadia Pharmaceuticals Co., Ltd1 Beijing Chest Hospital1 Hangzhou Endonom Medtech Co., Ltd.1 Huan Zhou1 Techpool Bio-Pharma Co., Ltd.1 Lingyi Biotech Co., Ltd.1 Innovent Biologics Technology Limited (Shanghai R&D Center)1 TYK Medicines, Inc1 Qilu Hospital of Shandong University1 Hangzhou Qihan Biotech Co., Ltd.1 Suzhou Zelgen Biopharmaceuticals Co.,Ltd1 Longbio Pharma1 Shanghai East Hospital1 GeneSail Biotech (Shanghai) Co., Ltd.1 Beijing Tiantan Hospital1 Clear sponsor filter
Target enrolment
to

Trials with a site in Hefei

2 of 19224 studies
Download
Status
Study
Lead sponsor
Phase
Enrol
Chinese sites
Start
Recruiting
Bambusa Therapeutics
Phase 1
68
Hefei, Guangzhou, Jiangmen, Qingyuan, Xinxiang, Yichang, Xuzhou, Nanchang
2025-09-05
Recruiting
Bambusa Therapeutics
Phase 1
99
Hefei, Wuhu, Beijing, Guangzhou, Changsha, Wuxi, Zhenjiang, Nanchang
2025-08-09
Rows per page Showing 1–2 of 2
1
Cite this view

Priya Life Science (2026). Clinical trial register: studies with a Chinese investigative site, filtered. Derived from ClinicalTrials.gov. Retrieved 11 November 2026. https://priyalifescience.com/clinical-trials-china/city/hefei

Query this register directly
GET /api/trials?country=cn&status=recruiting&format=json Try it now →

About this register

This register is built from ClinicalTrials.gov, the trial registry run by the U.S. National Library of Medicine. It includes every study on the registry that lists at least one investigative site in China and is recruiting, not yet recruiting, active but no longer recruiting, or enrolling by invitation: 19,224 studies in total at the last sync on 11 Nov 2026, 03:17 UTC. The full list can be downloaded as CSV or queried as JSON through the register API.

This page shows the 2 of those studies with a site in Hefei that also match the filters currently applied.

How many clinical trials are recruiting in Hefei?

2 of the 2 studies on this page are recruiting new participants as of the 11 Nov 2026, 03:17 UTC sync. A further 0 have not yet opened recruitment, 0 are active but closed to new participants, and 0 are enrolling by invitation only. Eligibility for any study is decided by its study team.

Summary by phase

Studies by phase (Hefei), 2 studies
PhaseStudiesRecruitingShare
Phase 122100%

Most active sponsors

Lead sponsors with the most studies (Hefei)
Lead sponsorStudiesRecruiting
Bambusa Therapeutics22
Listing here is informational and not medical advice; eligibility is determined by each study team. See also the Ireland, UK, EU, USA and India registers.